Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Family of high affinity, modified antibodies for cancer treatment

Family of high affinity, modified antibodies for cancer treatment

US Patent 6051225 · Granted Apr 18, 2000

Estimated economic value: $25,389,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of u2025
April and BAFF inhibitory immunomodulatory proteins and methods of use thereof2025
APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof2025
Combination immunotherapy compositions against cancer and methods2024
Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutant2024
Yeast-brachyury immunotherapeutic compositions2024
Yeast-brachyury immunotherapeutic compositions2024
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of u2023
Combination immunotherapy compositions against cancer and methods2023
Combination immunotherapy compositions against cancer and methods2023
Brachyury protein, non-poxvirus non-yeast vectors encoding Brachyury protein, an2022
Development of agonist epitopes of the human papillomavirus2022